Atorvastatin Enhances the Efficacy of Immune Checkpoint Therapy and Suppresses the Cellular and Extracellular Vesicle PD-L1.

Autor: Choe, Eun-Ji1 (AUTHOR), Lee, Chan-Hyeong1 (AUTHOR), Bae, Ju-Hyun1 (AUTHOR), Park, Ju-Mi1 (AUTHOR), Park, Seong-Sik1 (AUTHOR), Baek, Moon-Chang1 (AUTHOR) mcbaek@knu.ac.kr
Zdroj: Pharmaceutics. Aug2022, Vol. 14 Issue 8, p1660-1660. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje